InVivo Biosystems provides animal models for in-vivo analytical services, with disease models including C. elegans for transgenic services and Zebrafish for genome editing. The company offers assay kits, reagents, custom in-vivo testing, and in-vivo toxicity testing. Founded in 2019 in Eugene, United States, the company has raised $8.2M in Series A funding from investors including Rogue Venture Partners and Oregon Venture Fund. InVivo Biosystems provider of animal models for in-vivo analytical services. The company's disease model includes C. elegance for transgenic services and Zebrafish for genome editing services. It also offers assay kit, reagents like PCR master mix, custom in-vivo testing and in-vivo toxicity testing. Founded in 2019, headquartered in Eugene, United States.
InVivo Biosystems
Series AInVivo Biosystems provides animal models for in-vivo analytical services, with disease models including C. elegans for transgenic services and Zebrafish for genome editing. The company offers assay kits, reagents, custom in-vivo testing, and in-vivo toxicity testing. Founded in 2019 in Eugene, United States, the company has raised $8.2M in Series A funding from investors including Rogue Venture Partners and Oregon…
About
Business model
Genomics > Genomics Research > Research Models,
Life Sciences Platforms and Tools > Research Services > Animal Models > Xenograft Models > Zebra Fish models,
Biopharma Outsourcing > CRO > Preclinical Studies > Diversified > InVivo
Institutional investors
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.